Search

Your search keyword '"Mcnay, Laura"' showing total 121 results

Search Constraints

Start Over You searched for: Author "Mcnay, Laura" Remove constraint Author: "Mcnay, Laura"
121 results on '"Mcnay, Laura"'

Search Results

2. 32 Launching a Clinical Research Operation

3. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

4. SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

5. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

6. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

7. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

8. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

14. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

16. Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)

17. Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).

19. Benchmarking sites: how one clinical research project utilized benchmarks to gauge site performance and compliance

23. PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in Liberia.

24. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

26. Benchmarking SITES.

27. Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count >= 300 cells/mu L who were assigned to 7.5 MIU interleukin-2

30. 38 Pharmaceutical Management

35. 35 Data Management in Emergency Response Research

50. 25 Models in the COVID-19 Pandemic

Catalog

Books, media, physical & digital resources